Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 4:31 pm Purchase |
2025-02-07 | 13G | Nurix Therapeutics, Inc. NRIX |
Deep Track Capital, LP | 4,125,000 5.440% |
1,125,000 (+37.50%) |
Filing History |
| 2025-02-14 4:05 pm Purchase |
2025-02-07 | 13G | Nurix Therapeutics, Inc. NRIX |
Commodore Capital LP | 3,850,000 5.100% |
3,850,000 (New Position) |
Filing History |
| 2025-02-14 08:42 am Purchase |
2024-12-31 | 13G | Nurix Therapeutics, Inc. NRIX |
Deep Track Capital, LP | 3,000,000 4.240% |
2,170 (+0.07%) |
Filing History |
| 2025-01-10 9:33 pm Sale |
2024-09-30 | 13G | Nurix Therapeutics, Inc. NRIX |
ARK Investment Management LLC | 0 0.000% |
-3,194,999 (Position Closed) |
Filing History |
| 2024-12-06 11:34 am Purchase |
2024-11-29 | 13G | Nurix Therapeutics, Inc. NRIX |
FMR CORP | 10,306,351 14.500% |
10,306,351 (New Position) |
Filing History |
| 2024-11-14 9:00 pm Purchase |
2024-09-30 | 13G | Nurix Therapeutics, Inc. NRIX |
Redmile Group LLC | 6,970,307 9.900% |
1,948,421 (+38.80%) |
Filing History |
| 2024-11-14 4:21 pm Purchase |
2024-09-30 | 13G | Nurix Therapeutics, Inc. NRIX |
Baker Bros. Advisors LP | 6,751,565 9.700% |
1,799,113 (+36.33%) |
Filing History |
| 2024-11-14 4:08 pm Purchase |
2024-09-30 | 13G | Nurix Therapeutics, Inc. NRIX |
SANDS ARTHUR T | 3,272,832 4.700% |
564,936 (+20.86%) |
Filing History |
| 2024-11-14 12:48 pm Sale |
2024-11-14 | 13G | Nurix Therapeutics, Inc. NRIX |
WASATCH ADVISORS INC | 708,377 1.100% |
-2,041,368 (-74.24%) |
Filing History |
| 2024-11-08 10:52 am Purchase |
2024-09-30 | 13G | Nurix Therapeutics, Inc. NRIX |
WELLINGTON MANAGEMENT CO LLP | 3,482,105 5.410% |
2,319,789 (+199.58%) |
Filing History |
| 2024-11-07 5:37 pm Sale |
2024-09-30 | 13G | Nurix Therapeutics, Inc. NRIX |
MORGAN STANLEY MS |
1,758,053 2.700% |
-1,341,145 (-43.27%) |
Filing History |
| 2024-06-07 1:30 pm Purchase |
2024-05-31 | 13G | Nurix Therapeutics, Inc. NRIX |
BLACKROCK INC BLK |
6,042,150 10.200% |
1,398,414 (+30.11%) |
Filing History |
| 2024-02-14 4:26 pm Purchase |
2023-12-31 | 13G | Nurix Therapeutics, Inc. NRIX |
Redmile Group LLC | 5,021,886 9.900% |
122,114 (+2.49%) |
Filing History |
| 2024-02-14 4:21 pm Purchase |
2023-12-31 | 13G | Nurix Therapeutics, Inc. NRIX |
Baker Bros. Advisors LP | 4,952,452 9.990% |
150,498 (+3.13%) |
Filing History |
| 2024-02-14 10:03 am Sale |
2023-12-31 | 13G | Nurix Therapeutics, Inc. NRIX |
PRICE T ROWE ASSOCIATES INC | 2,391,866 4.900% |
-861,870 (-26.49%) |
Filing History |
| 2024-02-14 08:51 am Purchase |
2023-12-31 | 13G | Nurix Therapeutics, Inc. NRIX |
Deep Track Capital, LP | 2,997,830 6.180% |
280,659 (+10.33%) |
Filing History |
| 2024-02-14 08:00 am Purchase |
2023-12-31 | 13G | Nurix Therapeutics, Inc. NRIX |
SANDS ARTHUR T | 2,707,896 5.400% |
2,707,896 (New Position) |
Filing History |
| 2024-02-13 5:09 pm Purchase |
2023-12-29 | 13G | Nurix Therapeutics, Inc. NRIX |
The Vanguard Group | 2,598,097 5.360% |
2,598,097 (New Position) |
Filing History |
| 2024-02-09 1:56 pm Purchase |
2024-02-09 | 13G | Nurix Therapeutics, Inc. NRIX |
WASATCH ADVISORS INC | 2,749,745 5.700% |
211,113 (+8.32%) |
Filing History |
| 2024-02-09 1:47 pm Purchase |
2023-12-31 | 13G | Nurix Therapeutics, Inc. NRIX |
MORGAN STANLEY MS |
3,099,198 6.400% |
3,099,198 (New Position) |
Filing History |